These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24487788)

  • 1. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
    Durães C; Almeida GM; Seruca R; Oliveira C; Carneiro F
    Virchows Arch; 2014 Mar; 464(3):367-78. PubMed ID: 24487788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of inhibitory κB kinases mRNA expression in human gastric cancer.
    Gayed DT; Wodeyar J; Wang ZX; Wei X; Yao YY; Chen XX; Du Z; Chen JC
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30487159
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastric biomarkers: a global review.
    Baniak N; Senger JL; Ahmed S; Kanthan SC; Kanthan R
    World J Surg Oncol; 2016 Aug; 14(1):212. PubMed ID: 27514667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer.
    Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
    Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of gastric cancer: a 2017 update.
    Charalampakis N; Economopoulou P; Kotsantis I; Tolia M; Schizas D; Liakakos T; Elimova E; Ajani JA; Psyrri A
    Cancer Med; 2018 Jan; 7(1):123-133. PubMed ID: 29239137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients.
    Chen Y; Xia X; Wang S; Wu X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Røe OD; Zhou J
    J Gastroenterol; 2013 Sep; 48(9):1034-44. PubMed ID: 23307041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
    Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of gastric cancer: Current topics and future perspective.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2018 Jul; 24(26):2818-2832. PubMed ID: 30018477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on Management of Gastric Cancer.
    Johnston FM; Beckman M
    Curr Oncol Rep; 2019 Jun; 21(8):67. PubMed ID: 31236716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer.
    Kubo T; Kawano Y; Himuro N; Sugita S; Sato Y; Ishikawa K; Takada K; Murase K; Miyanishi K; Sato T; Takimoto R; Kobune M; Nobuoka T; Hirata K; Takayama T; Mori M; Hasegawa T; Kato J
    Gastric Cancer; 2016 Jul; 19(3):827-38. PubMed ID: 26486506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future biomarkers in gastric cancer.
    Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
    Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers for gastric adenocarcinoma: an update.
    Anderson C; Nijagal A; Kim J
    Mol Diagn Ther; 2006; 10(6):345-52. PubMed ID: 17154651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer.
    Aznab M; Maleksabet D; Khazaei S; Khazaei M; Rezaei M
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):1989-1994. PubMed ID: 31350955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
    Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
    Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.
    Cho JH; Lim JY; Cho JY
    World J Gastroenterol; 2017 Nov; 23(41):7407-7414. PubMed ID: 29151694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.